Sanofi, through its philanthropic organisation Foundation S, is celebrating the 25th anniversary of The Gaucher Initiative, a ...

Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaRecommendation based on IMROZ ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

T1D is an autoimmune, complex, and lifelong condition – and it can happen to anyone at any age even without family history.[1 ...

Today, Formation Bio, together with OpenAI and Sanofi, introduced Muse, an advanced AI-powered tool developed to accelerate and improve drug development by optimizing patient recruitment for clinical ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, ...

In September, the use of a Sanofi immuno-inflammatory medicine to treat chronic obstructive pulmonary disease (COPD) was ...

Access to innovation is proving increasingly difficult for UK cancer patients. Unpicking the policy barriers is important for ...

The current US Supreme Court has no fundamental understanding of a range of medical, engineering, technological, or ...

The percentage of diabetes is among women is alarming both in the cities and villages. By adopting a healthy lifestyle we can ...

An eczema drug jointly developed by pharmaceutical companies Regeneron and Sanofi continues to stand above all comers ...